L-tryptophan
Also called: tryptophan
L-tryptophan is an essential amino acid and a precursor of serotonin. The daily nutritional requirement is modest (5 mg/kg), but some adults take up to 4–5 g/day as a supplement, typically to improve mood or sleep.
- Category
- Amino acid and protein
- Forms
- L-tryptophan (oral supplements)
- Strongest evidence
- C Limited
- Reviewed
- 2026-10-30
Class 2 Moderately studied in people. A 2022 meta-analysis (Nutrition Reviews) pooled data from 4 articles on tryptophan supplementation and sleep. A 2021 review of 11 mood RCTs is not counted: its abstract describes tryptophan intake without stating how many trials gave L-tryptophan alone. [4]
Fact-checked 2026-10-30 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CBrain, mood and sleep3 topics
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Mood in healthy adults | C | A 2021 systematic review of 11 RCTs of tryptophan intake found 4 showed effects on negative or happy feelings versus control; no effect on aggressive feelings was found. [2] |
| Depression | C | A 2002 meta-analysis located 108 studies; only two (one of L-tryptophan, one of 5-HTP; 64 patients) met quality criteria, and the authors concluded these agents were insufficiently evaluated to assess effectiveness. [3] |
| Sleep quality | C | A 2022 meta-analysis (data from 4 articles) found tryptophan shortened wake after sleep onset, more so at 1 g or more per day, but did not affect other sleep components. [4] |
Main constituents: L-tryptophan; ingesting it raises brain tryptophan and stimulates its conversion to serotonin in neurons [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- The 2021 mood review's conclusion refers to 0.14–3 g of tryptophan per day taken in addition to the usual meal, in healthy adults. [2]
- The sleep meta-analysis compared daily doses below 1 g with 1 g or more. [4]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicines1 listed
Drugs that enhance serotonin function (for example, antidepressants)
Details and sources - Cancer evaluations (IARC, NTP)1 found
Each names the exact material tested, which may differ from a supplement.
Details and sources - FDA new dietary ingredient notifications1 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- Eosinophilia-myalgia syndrome (EMS): in 1989 a new syndrome, with debilitating muscle pain and a high eosinophil count, was quickly linked to supplemental tryptophan use; the cause was shown not to be tryptophan but a contaminant in certain production batches. [1]
- A 1990 investigation found that, among those whose tryptophan source was known, 29 of 30 case patients (97%) versus 21 of 35 controls (60%) had used tryptophan made by a single company; the authors concluded the 1989 outbreak resulted from a chemical constituent associated with specific manufacturing conditions at that company. [5]
- Of 6 manufacturers of L-tryptophan, only product made by Showa Denko KK was clearly associated with illness; EMS incidence in the United States diminished abruptly once L-tryptophan-containing products were recalled. [6]
- A 2023 review states that in vitro and in vivo studies of the suspected impurities have not reached clear and convincing conclusions; four of its authors disclosed employment by CJ CheilJedang. [7]
- Occasional side effects, mainly at higher doses (70–200 mg/kg), include tremor, nausea and dizziness; rarely, serotonin syndrome (delirium, myoclonus, hyperthermia, coma) occurs when tryptophan is combined with serotonin drugs. The safety database is small and largely anecdotal. [1]
Interactions
| With | What happens |
|---|---|
| Drugs that enhance serotonin function (for example, antidepressants) | Side effects may occur when tryptophan is taken with these drugs; in rare cases the combination causes serotonin syndrome. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- The 1989 EMS-associated tryptophan was made by fermentation with Bacillus amyloliquefaciens; case lots were associated with reduced powdered carbon in a purification step and a new bacterial strain, and an HPLC peak (peak E) was found in 9 of 12 case lots versus 3 of 11 control lots. [5]
Regulatory status
- US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [8]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- L-tryptophan, an essential amino acid and precursor of serotonin Essential amino acid [P5]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 1 entry naming L-tryptophan: a lysozyme hydrolysate preparation from egg albumin as a source of L-tryptophan (NDI 639 submitted 2010-02-22). A separate entry (NDI 1100, submitted 2018-11-12) names 5-hydroxytryptophan, a different compound. Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P1]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC evaluation of tryptophan was found in the IARC Monographs list of classifications (Volumes 1–142, checked 2026-10-29). [P2]
- NTP TR-71 (1978), Bioassay of L-Tryptophan for Possible Carcinogenicity: given in feed at 25,000 or 50,000 ppm, "L-tryptophan was not carcinogenic for Fischer 344 rats or B6C3F1 mice" under the conditions of the bioassay. [P3]
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- Drugs that enhance serotonin function (for example, antidepressants): Side effects may occur when tryptophan is taken with these drugs; in rare cases the combination causes serotonin syndrome (delirium, myoclonus, hyperthermia, coma). [P6]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- 1989 eosinophilia-myalgia syndrome epidemic: a 1990 case-control investigation linked it to a chemical constituent associated with specific manufacturing conditions at one company (reduced powdered carbon in purification; a new Bacillus amyloliquefaciens strain); an HPLC peak (peak E) was present in 9 of 12 case lots versus 3 of 11 control lots. [P7]
- A 2023 review states six components generated during L-tryptophan synthesis have been speculated to be related to EMS, but studies have not reached clear and convincing conclusions. [P8]
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; a firm may petition FDA for an exemption under 111.75(a)(1)(ii). [P4]
- HPLC impurity profile of each L-tryptophan lot — The 1989 EMS outbreak was associated with a chemical constituent detected by HPLC (peak E) in lots from one manufacturer. [P7]
Supply and conservation
- The manufacturer linked to the 1989 outbreak produced tryptophan by a fermentation process using Bacillus amyloliquefaciens. [P7]
Absorption in people
- Ingesting L-tryptophan raises brain tryptophan levels and stimulates its conversion to serotonin in neurons, which is thought to mediate its actions. [P6]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1–142 (last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
- National Toxicology Program. TR-71: Bioassay of L-Tryptophan for Possible Carcinogenicity (CASRN 73-22-3) (1978), 1978. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- Kikuchi AM, et al. A systematic review of the effect of L-tryptophan supplementation on mood and emotional functioning. J Diet Suppl 2021;18(3):316-333 (PMID 32272859), 2021. pubmed.ncbi.nlm.nih.gov
- Fernstrom JD. Effects and side effects associated with the non-nutritional use of tryptophan by humans. J Nutr 2012;142(12):2236S-2244S (PMID 23077193), 2012-12. pubmed.ncbi.nlm.nih.gov
- Belongia EA, et al. An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N Engl J Med 1990;323(6):357-365 (PMID 2370887), 1990-08-09. pubmed.ncbi.nlm.nih.gov
- Ko SM, et al. Safety concerns regarding impurities in L-tryptophan associated with eosinophilia myalgia syndrome. Food Chem Toxicol 2023;179:113946 (PMID 37453474), 2023-09. pubmed.ncbi.nlm.nih.gov
Sources
- Fernstrom JD. Effects and side effects associated with the non-nutritional use of tryptophan by humans. J Nutr 2012;142(12):2236S-2244S (PMID 23077193), 2012-12. pubmed.ncbi.nlm.nih.gov
- Kikuchi AM, et al. A systematic review of the effect of L-tryptophan supplementation on mood and emotional functioning. J Diet Suppl 2021;18(3):316-333 (PMID 32272859), 2021. pubmed.ncbi.nlm.nih.gov
- Shaw K, et al. Are tryptophan and 5-hydroxytryptophan effective treatments for depression? A meta-analysis. Aust N Z J Psychiatry 2002;36(4):488-491 (PMID 12169147), 2002-08. pubmed.ncbi.nlm.nih.gov
- Sutanto CN, et al. The impact of tryptophan supplementation on sleep quality: a systematic review, meta-analysis, and meta-regression. Nutr Rev 2022;80(2):306-316 (PMID 33942088), 2022-01-10. pubmed.ncbi.nlm.nih.gov
- Belongia EA, et al. An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N Engl J Med 1990;323(6):357-365 (PMID 2370887), 1990-08-09. pubmed.ncbi.nlm.nih.gov
- Kilbourne EM, et al. Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndrome. J Rheumatol Suppl 1996;46:81-88 (PMID 8895184), 1996-10. pubmed.ncbi.nlm.nih.gov
- Ko SM, et al. Safety concerns regarding impurities in L-tryptophan associated with eosinophilia myalgia syndrome. Food Chem Toxicol 2023;179:113946 (PMID 37453474), 2023-09. pubmed.ncbi.nlm.nih.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in amino acid and protein: 5-HTP (5-hydroxytryptophan) · Beta-alanine · BPC-157 · Branched-chain amino acids (BCAAs) · Carnosine (L-carnosine) · Collagen peptides · Creatine · Glutathione · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.